title: TLR9- and FcepsilonRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression.
abstract: Plasmacytoid dendritic cells (pDC) express not only TLR9 molecules through which ligation with CpG DNA favors Th1 responses but also possess IgE receptors (FcepsilonRI) implicated in allergen presentation and induction of Th2 responses. This dichotomy prompted an investigation to determine whether TLR9- and IgE receptor-mediated responses oppose one another in pDC by affecting receptor expression and associated functional responses. Results showed that IgE cross-linking reduced TLR9 in pDC and inhibited the capacity of these cells to secrete IFN-alpha when stimulated with the CpG oligodeoxynucleotide (ODN)-2216. In contrast, an approximately 15-fold reduction in FcepsilonRIalpha mRNA and a loss in surface protein were seen in pDC first exposed to TLR9 ligation with ODN-2216. Results indicated that type I IFNs partly mediated this effect, as rIFN-alpha also caused a significant approximately 4-fold reduction in FcepsilonRIalpha mRNA. Finally, this reduction in FcepsilonRIalpha mediated by ODN-2216 correlated with a selective suppression of allergen-induced CD4+ T cell proliferation, but not of responses resulting from tetanus toxoid. Overall, these results imply mechanisms by which specific innate and IgE-dependent immune responses counterregulate one another at the dendritic cell level and may have significant impact on whether an ensuing response is either of Th1 or Th2 in nature.
authors.affiliation: Department of Medicine, Division of Clinical Immunology, Johns Hopkins Asthma and Allergy Center, Johns Hopkins University, Baltimore, MD 21224, USA.
authors.forename: John T
authors.initials: JT
authors.lastname: Schroeder
authors.forename: Anja P
authors.initials: AP
authors.lastname: Bieneman
authors.forename: Huiqing
authors.initials: H
authors.lastname: Xiao
authors.forename: Kristin L
authors.initials: KL
authors.lastname: Chichester
authors.forename: Kavitha
authors.initials: K
authors.lastname: Vasagar
authors.forename: Sarbjit
authors.initials: S
authors.lastname: Saini
authors.forename: Mark C
authors.initials: MC
authors.lastname: Liu
mesh_terms: D000328:Adult; D003713:Dendritic Cells / Q000502:physiology*; D015536:Down-Regulation; D006801:Humans; D007113:Immunity, Innate; D007073:Immunoglobulin E / Q000494:pharmacology; D007377:Interleukin-3 / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects; D008875:Middle Aged; D009838:Oligodeoxyribonucleotides / Q000494:pharmacology; D010641:Phenotype; D010950:Plasma Cells / Q000166:cytology; D017455:Receptors, IgE / Q000032:analysis / Q000502:physiology*; D051217:Toll-Like Receptor 9 / Q000032:analysis / Q000502:physiology*
chemical_list: C408982:CPG-oligonucleotide; D007377:Interleukin-3; D009838:Oligodeoxyribonucleotides; D017455:Receptors, IgE; C495371:TLR9 protein, human; D051217:Toll-Like Receptor 9; D007073:Immunoglobulin E